US SEC Trading Suspension Halt Orders — March 09, 2026

Board resignation of Audit Chair Kender not due to disagreements with operations/policies, reducing toxicity of departure

Rapid appointment of Dr. Roger Hajjar to Audit Committee on March 4 restored minimum 3 independent members within 1 day

Plans to appoint qualified financial expert within 180-day cure or next AGM, signaling proactive compliance path

Nasdaq notice does not currently impact CYPH listing or trading on Capital Market, preserving status quo

Eligible for additional 180-day extension if meets other standards (e.g., market value of public shares), with intent notice for reverse split

CYPH closing bid below $1.00 for 30 consecutive days, violating Rule 5550(a)(2), eroding investor confidence

No assurance of regaining $1.00 bid for 10 consecutive days or reverse split success, heightening uncertainty

8-K under Item 3.01 flags delisting/failure to meet listing standards, with high risk level and no disclosed remediation

No financial metrics, transaction details, or positive offsets provided, amplifying material negative event (10/10 materiality)

Absence of insider buying or positive capital allocation (dividends/buybacks) amid compliance crises signals low management conviction

3/3 filings lack YoY/QoQ financial improvements or ROE/debt trends, vs. typical filings with growth offsets

Temporary violation of Nasdaq Rule 5605(c)(2)(A) lacking 3 independent audit members post-Kender resignation March 3

Still lacks independent audit financial expert post-Hajjar appointment, reliant on 180-day cure

CYPH below $1.00 for 30 business days, with 180-day clock to Aug 31, 2026 for 10-day sustain

Exploring reverse split but no success guarantee, potential shareholder dilution

Direct 8-K notice of delisting or listing standard failure (Item 3.01), no reasons or cures disclosed

High risk of post-delisting trading/liquidity erosion, no balance sheet or dollar impacts to assess severity

Cluster of Nasdaq violations (audit, bid, delisting) foreshadows trading suspensions, no period financials to counter

Zero disclosed positive insider activity, capital allocation, or operational metrics across 3 filings

Potential OTC transfer post-delisting, with 205KB filing size indicating minimal disclosure

Proactive board refill and 180-day window (from March 3) positions for compliance rebound, mixed sentiment (7/10 materiality) vs. peers

Kender's move to Seres (announced March 2) unrelated to Longeveron ops, potential network for future recruits

Additional 180 days possible if meets public float standards, monitor for intent notice/reverse split

Trading unaffected now, alpha in short-term dip-buy if bid price catalysts emerge pre-Aug 31

Fresh delisting notice (March 9) with bearish sentiment/high risk, no offsets for momentum short

3/3 high-materiality suspensions cluster ideal for paired short trade, esp. vs. compliant small-caps

Forward cure periods (180-360 days) create event-driven long if financials improve undisclosed

Next shareholders' meeting for financial expert election, potential compliance resolution

Track for 10-consecutive $1+ days, undervalued if crypto rebound aids

3/3 companies hit with audit/bid/delisting violations (high materiality 7-10/10), no YoY financial offsets, signaling micro-cap fragility amid 2026 volatility

Cypherpunk/Longeveron exemplify Rule 5550/5605 breaches (30-day bid <1, audit gaps), mixed/negative sentiment, implications for 100+ low-float names

CIMG's Item 3.01 filing (10/10 materiality) as outlier, but portfolio pattern warns of contagion in biotech/crypto/micro-caps lacking disclosure depth

All cite 180-day windows (extendable), no capital allocation/insider positives, theme of prolonged uncertainty vs. swift halts

Zero enriched financial ratios/operational metrics across filings, bearish aggregate vs. typical 8-Ks with trends, eroding transparency trust

Monitor for qualified independent audit expert hire within 180 days of March 3 or next AGM [By Sep 2026]

Track restoration of full Rule 5605(c)(2)(A) adherence post-Hajjar [Ongoing thru 2026]

Watch CYPH for $1.00+ closing 10 consecutive days to halt 180-day clock [By Aug 31, 2026]

Nasdaq follow-up on additional 180 days if public float met, reverse split intent [By Sep 2026]

Post-March 9 notice developments, potential transfer/OTC move or halt [Immediate thru Q2 2026]

Any follow-on filings on liquidity/trading impacts, balance sheet effects [Next 30 days]

Scan for buys/sells/pledges in LGVN/CYPH/CIMG amid crises, conviction gauge [Weekly]

Scheduled events or appeals on suspensions/delisting per forward plans [Q2-Q3 2026]